Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it
As demand for trial sites increases, more investigators are overburdened or experiencing burnout. What can the industry do to help?
Better Science, Better Medicine: How Clinical Research Advances Women’s Health
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented.
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success
Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites.
Why Former FDA & Verily Exec Amy Abernethy Is Launching a New Venture
This week, longtime healthcare veterans Amy Abernethy and Brad Hirsch teamed up to launch Highlander Health — a Dallas-based startup focused on accelerating clinical evidence generation.
A Tailor-made Approach to Simplify Observational Research
A direct-to-patient model for observational research will ease the participation burden, better incorporate the patient voice, and empower individuals to take control of their health – all while meeting the growing demands for robust evidence in developing new drugs and therapeutics.
AI-Driven Breakthroughs: Transforming Patient Care through Research Consulting
This not only enhances the quality of care and patient satisfaction but also optimizes operational efficiency.
presented by
The Top 6 Best Analytics Tools for Health Care Revenue in 2025
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Biden’s Executive Order for Studying Women’s Health: How to Not Squander This Opportunity
Given our questionable track record of driving consistent progress, it’s important that we create a roadmap to optimize the success for this exciting moment.
Labcorp Shells Out $146M to Buy Enzo Biochem’s Clinical Lab Business
Enzo BioChem’s sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile, diagnostics and lab testing giant Labcorp is in the middle of its own corporate shakeup as it readies its clinical trials business for a spinoff as a standalone, publicly traded company.
Paradigm Launches with $203M to Transform Clinical Trial Recruitment
Paradigm, a new startup co-incubated by ARCH Venture Partners and General Catalyst, recently launched with $203 million in Series A funding. The company is focused on improving equitable access to trials by creating a less fragmented and more efficient clinical research ecosystem.
Former Execs From Datavant & Grand Rounds Create Health Data Startup
Crescendo Health recently launched with a $3.4 million initial investment. The startup provides clinical researchers with software tools that make it easier to gather study participants' longitudinal health data.
presented by
The Top Surgical Instruments Needed for Extractions
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
The role of AI and machine learning in revolutionizing clinical research
The goal of implementing artificial intelligence and machine learning in clinical research is not to replace humans with digital tools but to increase their productivity.
Osmind scores $40M investment to aid in mental health research and treatment
The Series B funding round was led by DFJ Growth. Osmind helps the medical community administer treatments, and track and study the effectiveness of those treatments for 14 million U.S. patients living with moderate and serious mental illness, according to the company.
What the “Great Resignation” means for clinical research
Staffing shortages can slow down trial timelines and negatively affect patients, who have less time with the physicians and nurses providing their care. But a few flexible, integrated systems that work for both clinical research sites and sponsors could help alleviate these issues and speed up research.
Technology considerations to promote inclusion, equity and diversity in clinical research
Underrepresented groups traditionally were thought to have limited access to technology. But internet access is on the rise and researchers can take steps to increase participant diversity and be more inclusive.
IQVIA adds to growing lab biz with $198M deal for Myriad contract services unit
IQVIA is paying nearly $200 million to purchase a Myriad Genetics subsidiary that provides pharmaceutical contract services, a deal that will put the new acquisition in the company's Q2 Solutions unit. The deal follows IQVIA's April announcement that it had secured full ownership of Q2, which had been a joint venture with Quest Diagnostics.